Trials evaluate unwitnessed strokes, new uses for drugsThe use of tPA for patients who had unwitnessed strokes, the use of natalizumab to reduce infarct volume following acute ischemic stroke and the use of glyburide to reduce brain edema after a large hemispheric stroke were the focus of three late-breaking clinical trial results presented during the final plenary at ISC 2016 in Los Angeles. The three trials were MR WITNESS, ACTION and GAMES RP. READ MORE
ISC updates advances in stroke treatmentThe International Stroke Conference 2016 proved that the meeting's past is again its prologue. READ MORE
Expand your education with Stroke OnDemand™ PremiumYou still can experience the in-depth educational programming of ISC 2016 with Stroke OnDemand™ Premium. READ MORE- Thanks to ISC 2016 supportersThanks to the supporters of ISC 2016. READ MORE
MENUMENU